Literature DB >> 3482987

HLA and rheumatoid arthritis: susceptibility or severity?

D Jaraquemada1, W Ollier, J Awad, A Young, H Festenstein.   

Abstract

An analysis of data collected on 440 British Caucasoid rheumatoid arthritis patients has confirmed positive association with HLA-DR4, Dw4, DRw53, and A2 and negative associations with HLA-DR2, 3, and 7. HLA-DR4 is more associated with RA 'severity' than with RA 'susceptibility', when measured by the parameters of ARA classification, seropositivity, severity of erosions and extra-articular manifestations. The association between HLA-A2, Cw3, Bw62, DR4, DRw53, and Dw4 and extra-articular disease has been confirmed in this study. The analysis of HLA and RA severity with respect to sex showed high frequencies of DR4, Dw4, and DRw53 in females, which increased in those with severe erosions, seropositivity or extra-articular disease. In males with RA, the disease appears to be associated not only with DR4, Dw4 and DRw53, but also with A2, Cw3 and Bw62. However, no significant differences in these antigen frequencies were found between male patients with severe RA and those without. Despite a significant decrease in the frequencies of DR3, B8 and A1 in most RA patient subsets, RA patients with Sjogren's syndrome showed a marked increase of A1 and B8 and patients with auto-antibodies had a significant increase in HLA-DR3 frequency when compared with patients without these features.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3482987

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  6 in total

1.  Genes associated with rheumatoid arthritis and mild inflammatory arthritis. I. Major histocompatibility complex class I, II, and III allotypes.

Authors:  A H Puttick; D C Briggs; K I Welsh; R Vaughan; E A Williamson; M Boyce; R K Jacoby; V E Jones
Journal:  Ann Rheum Dis       Date:  1990-04       Impact factor: 19.103

2.  Anti-neutrophil cytoplasm antibodies (ANCA) in rheumatoid arthritis: relationship to HLA-DR phenotypes, rheumatoid factor, anti-nuclear antibodies and disease severity.

Authors:  E Röther; D Metzger; B Lang; I Melchers; H H Peter
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 3.  Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2021-02-24       Impact factor: 28.314

4.  Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community.

Authors:  W Thomson; L Pepper; A Payton; D Carthy; D Scott; W Ollier; A Silman; D Symmons
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

5.  HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease.

Authors:  Seth P Epstein; Neha Gadaria-Rathod; Yi Wei; Maureen G Maguire; Penny A Asbell
Journal:  Exp Eye Res       Date:  2013-04-06       Impact factor: 3.467

6.  Large-Scale Simultaneous Testing of Cross-Covariance Matrices with Applications to PheWAS.

Authors:  Tianxi Cai; T Tony Cai; Katherine Liao; Weidong Liu
Journal:  Stat Sin       Date:  2019-04       Impact factor: 1.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.